Together, this study showed that GTF2E2 might act as an oncogene and negative prognostic factor in ESCC, thus potentially serving as a promising biomarker for early detection of recurrence in ESCC patients after surgery. The gene discussed is GTF2E2; the disease is esophageal squamous cell carcinoma.